inhibit
Navigation Links
inhibit at biology products
Mouse Anti-C1-inhibitor (C1-INH) Monoclonal Antibody, Unconjugated, Clone 8F3 from AntibodyShop A/S
Description:C1-inhibitor (C1-INH)...Company:AntibodyShop A/S
QIAGEN RNase Inhibitor (7500 U) from QIAGEN
Description:For potent inhibition of RNase A-type ribonucleases QIAGEN RNase Inhibitor is a protein of nonhuman origin that binds noncovalently and inactivates a variety of ribonucleases (e.g., RNase A, B, and C). It does not interfere with RNase T1, T2, H, U1, U2, or CL3. QIAGEN RNase Inhibitor inhibits greater than 90% of RNase activity, whereas HPRI (human placental RNase inhibi...Company:QIAGEN
RNase Inhibitor from Applied Biosystems
Description:RNase Inhibitor (Ribonuclease inhibitor) is a 50 kDa recombinant enzyme used to inhibit RNase activity. It does not contain DNase or endonuclease activity....Company:Applied Biosystems
Recombinant RNasin® Ribonuclease Inhibitor from Promega
Description:Natural and Recombinant RNasin Ribonuclease Inhibitors have broad spectrum RNase inhibitory properties, including the inhibition of eukaryotic RNases of the neutral type (1). The 50kDa protein exerts its inhibitory effect by noncovalently binding to RNases in a 1:1 ratio. The Ki value for the binding of RNasin Ribonuclease Inhibitor to RNase (e.g., RNase A) is approximately 1014M (24). Promega of...Company:Promega
GeneChoice RNA Safe Recombinant Ribonuclease Inhibitor from GeneChoice, Inc.
Description:Ribonuclease Inhibitor is a recombinant protein that has been shown to help maintain the integrity of RNA in the preparation of cDNA by reverse transcription, in vitro RNA transcription, and in vitro protein synthesis. RNA Safe Inhibitor tightly binds RNases in a 1:1 ratio. It inhibits a broad range of eukaryotic RNases such as RNase A, RNase B, RNase C, and human placental RNase. RNA Safe does...Company:GeneChoice, Inc.
RNaseOUT Recombinant Ribonuclease Inhibitor from Invitrogen
Description:RNaseOUT Recombinant Ribonuclease Inhibitor is a potent noncompetitive inhibitor of pancreatic-type ribonucleases such as RNase A. Like other RNase inhibitors RNaseOUT Recombinant Ribonuclease Inhibitor is an acidic protein with a molecular weight ~52 kDa. RNaseOUT inhibits RNase A RNase B and RNase C....Company:Invitrogen
RNase Inhibitor (Cloned) from Ambion
Description:Ambion's RNase Inhibitor is a recombinant human protein produced in E. coli and is a potent inhibitor of neutral pancreatic RNase A type enzymes. The mode of inhibition is noncompetitive; the inhibitor tightly binds RNases in a 1:1 ratio. The enzyme has been shown to inactivate RNases present in many tissues and cell types. Addition of the ribonuclease inhibitor has been shown to be useful whene...Company:Ambion
gamma-Secretase Inhibitor IV, Unconjugated from Calbiochem
Description:= 2.7 μM) in HEK293 cells stably transfected with the Amyloi...Company:Calbiochem
Plasminogen Activator Inhibitor (PAI-1) Colorimetric Assay Kit from AMERICAN DIAGNOSTICA
Description:Spectrolyse (pL) PAI kit is a two-stage indirect enzymatic assay for the quantitative determination of Plasminogen Activator Inhibitor (PAI-1) activity in plasma. Sample Type: plasma...Company:AMERICAN DIAGNOSTICA
Rnase-free Ribonuclease Inhibitor from Chimerx
Description:A very potent Rnase free Ribonuclease Inhibitor that is effective over a broad range of temperatures and pH's. This protein does not inhibit SP6, T7, or T3 RNA polymerase, AMV and M-MLV reverse transcriptase or Taq DNA polymerase. For bulk purchases contact lloconne@molbiores.com....Company:Chimerx
TypeOne Restriction Inhibitor from EPICENTRE Biotechnologies
Description:DNA transformation can be difficult to achieve in many bacterial strains due to the presence of one or more restriction and modification (R-M) systems that cleave unmodified DNA that is recognized as "foreign". TypeOne™ Restriction Inhibitor provides a powerful method for increasing transformation efficiencies in bacterial strains with type I R-M systems. Developed as a unique preparation o...Company:EPICENTRE Biotechnologies
PARP Inhibitor XI, DR2313 from Calbiochem
Description:= 200 nM and 240 nM for rhPARP1 and rmPARP2, respectively) with little activity against the dehydrogenase activity o...Company:Calbiochem
MMP-2/MMP-9 Inhibitor IV [SB-3CT] from CHEMICON
Description:MMP-2 / MMP-9 Inhibitor IV is a potent, selective, slow binding and mechanism based inhibitor of human gelatinases. • Molecular weight: 306.4 • Molecular Formula: C(15)H(14)O(3)S(2). • The inhibitor is soluble in DMSO (100mg/mL)....Company:CHEMICON
MMP-2 Inhibitor I from Calbiochem
Description:...Company:Calbiochem
Bax-Inhibiting Peptide, Negative Control from Calbiochem
Description:O. M.W. 600.8. </...Company:Calbiochem
PTP1B Inhibitor from Calbiochem
Description:298</su...Company:CalbiochemDescription:Rab GDP dissociation inhibitor beta...
Company:GenWay Biotech, Inc.
Protease Inhibitor Cocktail Set I from Calbiochem
Description:...Company:Calbiochem
Caspase Inhibitor Ac-DEVD-CHO, Unconjugated from Promega
Description:Ac-DEVD-CHO is an inhibitor of caspase-3/7 (DEVDase) activity. The concentration of inhibitor required to inhibit caspase activity must be determined empirically for each system. Ten micromolar inhibitor is sufficient to inhibit caspase activity in extracts of apoptotic THP-1 cells....Company:Promega
Caspase-6 Inhibitor Z-VEID-FMK from BioVision
Description:Recommend to use at 1000X dilutions for cell culture (e.g. Add 1 ul to 1 ml of culture medium.)...Company:BioVision
Caspase-8 Inhibitor Z-IETD-FMK from BioVision
Description:Recommend to use at up to 5000X dilutions for cell culture (e.g. Add 1 ul to 1 ml of culture medium.)...Company:BioVisionDescription:...
Company:BiolineDescription:Timp-4 has been reported in heart tissues, and is produced by some fibroblasts in cell culture conditions. Treatment of cells with phorbol ester TPA stimulates production of TIMP-4 in some cell types, but the low protein levels produced often require concentration of cell culture media to visualize the bands by Western Blotting....
Company:CHEMICON
Caspase-3/7 Inhibitor I from Calbiochem
Description:...Company:Calbiochem
Other TagsPERKOther Contentsquadricepsquadriplegiaquitquitquitquitrabbitrabbitrabbitrabbitrabbitrabbitrabbitrabbitrabiesrabiesrabiesracingracingracingracing
(Date:7/23/2008)...verting livestock manure into a domestic renewable...meet up to three per cent of North America,s entir...ction in greenhouse gas emissions (GHGs), accordin...y, in the Institute of Physics, Environmental Res... The Energy and Emissions Benefits of Converting M...
(Date:7/23/2008)...UMBUS, Ohio Wealthy nations willing to collective...he emission of roughly half a billion metric tons ...new research suggests. , It would take about th...ical deforestation in the world, one of the top co...s estimate. , If adopted, this type of program c...
(Date:7/23/2008)...CLA "world summit" will bring together internation...ing the U.S., Russia, China, Japan, Australia and ...m July 27 to Aug. 2. , "We are bringing toget...cient life," said summit organizer J. William Scho...Geophysics and Planetary Physics, Center for the S...
(Date:7/23/2008)...entists at the National Institute of Standards and...easure the formation of clumps of proteins in prot...tudy* clarifies the conditions under which scienti...hfully measuring the formation of protein aggregat...ty control and safety in biologic drug manufacturi...
Breaking Biology News(10 mins):Cow power could generate electricity for millions 2Paying to save tropical forests could be a way to reduce global carbon emissions 2Paying to save tropical forests could be a way to reduce global carbon emissions 3Paying to save tropical forests could be a way to reduce global carbon emissions 4UCLA 'world summit' to explore ancient life on Earth, and beyond 2NIST trumps the clumps: Making biologic drugs safer 2Cipla Offers Modest AIDS Drug Price Cut 3A Not Nearly Enough says AHF 8266 1Cipla Offers Modest AIDS Drug Price Cut 3A Not Nearly Enough says AHF 8266 2Cipla Offers Modest AIDS Drug Price Cut 3A Not Nearly Enough says AHF 8266 3Artistic Magical Mystical Tours 2200 1Artistic Magical Mystical Tours 2200 2Neupro 28R 29 Filed with the FDA for the Treatment of Restless Legs Syndrome 8265 1Neupro 28R 29 Filed with the FDA for the Treatment of Restless Legs Syndrome 8265 2Neupro 28R 29 Filed with the FDA for the Treatment of Restless Legs Syndrome 8265 3Neupro 28R 29 Filed with the FDA for the Treatment of Restless Legs Syndrome 8265 4Isis Announces ISIS 333611 Granted Orphan Drug Status for Treatment of ALS 8263 1Isis Announces ISIS 333611 Granted Orphan Drug Status for Treatment of ALS 8263 2Isis Announces ISIS 333611 Granted Orphan Drug Status for Treatment of ALS 8263 3(Date:7/25/2008)...ON, July 25 /PRNewswire/ -- The Elekta Family of C... treatment solutions at the 2008,American Associat...g,demonstrating how the joint forces of Elekta, I... therapy planning and delivery solutions that,stre...perience for,patients, as well as enhance clinicia...
(Date:7/25/2008)...ds fluid back-up in esophagus can cause immune sys...ay News) -- The first evidence linking gastroesoph...scovered by Duke University Medical Center researc...ns was first noted in the 1970s, and since then st...rcent of asthma patients also experience GERD symp...
(Date:7/25/2008)... The Retina Group of New York will...ted macular degeneration especially designed for s...e Public Library at 116 Merritts Road, Farmingdale.... Attendance is free and refreshments will be prov...6) 939-6100. , Hicksville...
(Date:7/25/2008)... This donation will be used to fac...ve services for children , ... ( www.ivci.com ), a leading integrator of enterp...tion video conferencing, telepresence, audio visua...announced today that it has donated video conferen...
Breaking Medicine News(10 mins):Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 2Health News:Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting 3Health News:People With GERD More Likely to Develop Asthma 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 2Health News:Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors 3Health News:Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi 2[0] Elekta Family of Companies to Highlight Cancer Treatment Solutions at 2008 AAPM Annual Meeting[0] People With GERD More Likely to Develop Asthma[0] Retina Group of New York To Present Seminar on Age-Related Macular Degeneration; The Leading Cause of Visual Loss in Seniors [0] Mt. Sinai's Children's Trauma Institute Treatment and Service Adaptation Center Receives Video Conferencing Donation From IVCi
| Copyright © 2003-2008 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |